WORCESTER, Mass., July 16, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, received a purchase order for the approximate amount of $300,000 through its Generex MENA office from a distributor in Saudi Arabia.
